Physician profile
John Michael Fox
NPI 1528320454
$1,513.51
in general payments reported to CMS, 2019-2025
16 companies · $1,272 in 2025
The $1,272 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $53.37 · 2024: $188 · 2025: $1,272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aop Health US, LLC | $515.87 | 2025 | Rapiblyk |
| Abbott Laboratories | $201.52 | 2025 | Amplatzer |
| Abiomed | $151.64 | 2023-2025 | Impella |
| Pfizer INC. | $144.90 | 2024-2025 | |
| Masimo Corporation | $101.60 | 2024 | Set and Rainbow Set |
| E.R. Squibb & Sons, L.L.C. | $64.70 | 2024-2025 | Camzyos, Eliquis |
| Heartflow, INC. | $64.56 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $61.83 | 2025 | Opsumit |
| Alnylam Pharmaceuticals INC. | $41.89 | 2025 | Onpattro |
| Amgen INC. | $39.69 | 2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $25.77 | 2024 | Lifevest |
| Cardiva Medical, INC. | $25.16 | 2025 | Optowire |
| Kiniksa Pharmaceuticals, LTD. | $22.71 | 2023 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $20.67 | 2025 | |
| Scpharmaceuticals INC. | $15.60 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $15.40 | 2025 | Attruby |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.